| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tachykinin receptor 2 | 0.700 | 0.500 | 8.8E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
tachykinin precursor 1 | 0.424 | 0.923 | 0.75 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
sphingomyelin phosphodiesterase 3 | 0.659 | 0.615 | 0.59 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
RELA proto-oncogene, NF-kB subunit | 0.406 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
BCL2 like 1 | 0.493 | 0.885 | 0.94 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
bradykinin receptor B2 | 0.585 | 0.808 | 0.12 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
C-X3-C motif chemokine ligand 1 | 0.478 | 0.808 | 0.61 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
hypoxia inducible factor 3 subunit alpha | 0.682 | 0.538 | 1.5E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
solute carrier family 2 member 4 | 0.528 | 0.769 | 4.7E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
mitofusin 1 | 0.644 | 0.577 | 2.5E-10 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
histone deacetylase 5 | 0.552 | 0.769 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
cytochrome b-245 beta chain | 0.452 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
endothelin converting enzyme 1 | 0.541 | 0.769 | 0.96 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
endothelial PAS domain protein 1 | 0.454 | 0.731 | 0.60 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
epoxide hydrolase 2 | 0.568 | 0.654 | 1.8E-21 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
5'-aminolevulinate synthase 1 | 0.705 | 0.462 | 0.11 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
cytochrome b-245 alpha chain | 0.520 | 0.769 | 8.9E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
C-X3-C motif chemokine receptor 1 | 0.457 | 0.885 | 6.1E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
collagen type IV alpha 1 chain | 0.484 | 0.731 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
nicotinamide phosphoribosyltransferase | 0.502 | 0.808 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 |